Pompe Disease Market-our new study reveals trends, R&D progress, and predicted revenues
Where the Pompe Disease market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 150+ page report provides 80+ tables, 30+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Pompe Disease market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Report Scope
Global Pompe Disease market 2020-2030 is segmented on the basis of Therapy Type, Dosage Form, End User, and geography.
• Revenue and growth forecasts from 2020 to 2030 for the Global Pompe Disease Market by Therapy Type:
– Enzyme Replacement Therapy
– Substrate Reduction Therapy
• Revenue and growth forecasts from 2020 to 2030 for the Global Pompe Disease Market by Type:
– Solid
– Liquid
• Revenue and growth forecasts from 2020 to 2030 for the Global Pompe Disease Market by Disease Indication:
– Hospitals and Clinics
– Research and Academic Institutes
• Revenue and growth forecasts from 2020 to 2030 for the Global Pompe Disease Market by Region:
– North America: US, Canada
– Europe: Germany, UK, Italy, France, Spain, Rest of Europe
– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific
– Latin America: Brazil, Mexico, and Rest of Latin America
– Middle East & Africa: GCC, South Africa, Rest of LAMEA
• Our study discusses the selected leading companies that are the major players in the Pompe Disease industry:
– Genzyme
– BioMarin Pharmaceutical
– Amicus Therapeutics
– Avrobio, Inc.
– Centogene AG
– Audentes Therapeutics
– EpiVax
– Oxyrane
– Sangamo BioSciences
– Valerion Therapeutics
How the Pompe Disease Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2030 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.
– Revenue forecasts to 2030 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Pompe Disease market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pompe Disease market and leading companies. You will find data, trends and predictions.
The Pompe Disease Market 2020-2030 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Pompe Disease industry.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pompe Disease Market Report 2020-2030: Forecasts by Therapy Type (Enzyme Replacement Therapy and Substrate Reduction Therapy), Dosage Forms (Solid and Liquid), End-user (Hospitals and Clinics, Research and Academic Institutes), and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Market Definition
1.2. Why Should You Read This Report?
1.3. How This Report Delivers?
1.4. Key Questions Answered by This Analytical Report:
1.5. Who is this Report for?
1.6. Research Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. About Visiongain
2. Introduction To The Pompe Disease Market
2.1. What are Pompe Disease Therapy Types?
2.2. Global Pompe Disease Market Segmentation
2.3. Assumptions For The Study
3. Qualitative Analysis of the Global Pompe Disease Market
3.1. SWOT Analysis of The Global Pompe Disease Market
3.2. PESTLE Analysis
3.3. Market Trends
3.4. Drivers
3.4.1. Limited number of treatment options
3.4.2. Requirement for long-term treatment
3.5. Restraints
3.5.1. High cost of these drugs
3.6. Opportunity
3.6.1. Development of gene therapy
4. Global Pompe Disease Market, by Therapy Type, 2020-2030
4.1. Global Pompe Disease Market Forecast, 2020-2030
4.2. Enzyme Replacement Therapy
4.2.1. Pompe Disease Market for Enzyme Replacement Therapy by Region: Market Forecasts 2020-2030
4.3. Substrate Reduction Therapy
4.3.1. Pompe Disease Market for Substrate Reduction Therapy by Region: Market Forecasts 2020-2030
5. Global Pompe Disease Market, by Dosage Forms, 2020-2030
5.1. Global Pompe Disease Market Forecast, 2020-2030
5.2. Solid
5.2.1. Pompe Disease Market for Solid by Region: Market Forecasts 2020-2030
5.3. Liquid
5.3.1. Pompe Disease Market for Liquid by Region: Market Forecasts 2020-2030
6. Global Pompe Disease Market, by End User, 2020-2030
6.1. Global Pompe Disease Market Forecast, 2020-2030
6.2. Hospitals & Clinics
6.2.1. Pompe Disease Market for Hospitals & Clinics by Region: Market Forecasts 2020-2030
6.3. Research and Academic Institutes
6.3.1. Pompe Disease Market for Research and Academic Institutes by Region: Market Forecasts 2020-2030
7. Leading National Markets Forecast 2020-2030
7.1. Geographical Breakdown of Global Pompe Disease Market, 2019
8. North America Pompe Disease Market, 2020-2030
8.1. U.S. Pompe Disease Market Forecast, 2020-2030
8.2. U.S Pompe Disease Market, Trends and Developments
8.3. Canada Pompe Disease Market Forecast, 2020-2030
8.4. Canada Pompe Disease Market, Trends and Developments
9. Europe Pompe Disease Market, 2020-2030
9.1. Germany Pompe Disease Market Forecast, 2020-2030
9.2. Germany Pompe Disease Market, Trends and Developments
9.3. France Pompe Disease Market Forecast, 2020-2030
9.4. France Pompe Disease Market, Trends and Developments
9.5. UK Pompe Disease Market Forecast, 2020-2030
9.6. UK Pompe Disease Market, Trends and Developments
9.7. Italy Pompe Disease Market Forecast, 2020-2030
9.8. Italy Pompe Disease Market, Trends and Developments
9.9. Spain Pompe Disease Market Forecast, 2020-2030
9.10. Spain Pompe Disease Market, Trends and Developments
9.11. Rest of Europe Pompe Disease Market Forecast, 2020-2030
9.12. Rest of Europe Pompe Disease Market, Trends and Developments
10. Asia Pacific Pompe Disease Market, 2020-2030
10.1. Japan Pompe Disease Market Forecast, 2020-2030
10.2. Japan Pompe Disease Market, Trends and Developments
10.3. China Pompe Disease Market Forecast, 2020-2030
10.4. China Pompe Disease Market, Trends and Developments
10.5. India Pompe Disease Market Forecast, 2020-2030
10.6. India Pompe Disease Market, Trends and Developments
10.7. Australia Pompe Disease Market Forecast, 2020-2030
10.8. Australia Pompe Disease Market, Trends and Developments
10.9. Rest of APAC Pompe Disease Market Forecast, 2020-2030
10.10. Rest of APAC Pompe Disease Market, Trends and Developments
11. Latin America Pompe Disease Market, 2020-2030
11.1. Brazil Pompe Disease Market Forecast, 2020-2030
11.2. Brazil Pompe Disease Market, Trends and Developments
11.3. Mexico Pompe Disease Market Forecast, 2020-2030
11.4. Mexico Pompe Disease Market, Trends and Developments
11.5. Rest of Latin America Pompe Disease Market Forecast, 2020-2030
11.6. Rest of Latin America Pompe Disease Market, Trends and Developments
12. MEA Pompe Disease Market, 2020-2030
12.1. GCC Countries Pompe Disease Market Forecast, 2020-2030
12.2. GCC Countries Pompe Disease Market, Trends and Developments
12.3. South Africa Pompe Disease Market Forecast, 2020-2030
12.4. South Africa Pompe Disease Market, Trends and Developments
12.5. Rest of MEA Pompe Disease Market Forecast, 2020-2030
12.6. Rest of MEA Pompe Disease Market, Trends and Developments
13. Leading Pompe Disease Companies
13.1. Genzyme
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.3. Sales Analysis
13.2. BioMarin Pharmaceutical
13.2.1. Company Overview
13.2.2. Product Portfolio
13.2.3. Sales Analysis
13.3. Amicus Therapeutics
13.3.1. Company Overview
13.3.2. Product Portfolio
13.3.3. Sales Analysis
13.4. Avrobio, Inc.
13.4.1. Company Overview
13.4.2. Product Portfolio
13.4.3. Sales Analysis
13.5. Centogene AG
13.5.1. Company Overview
13.5.2. Product Portfolio
13.5.3. Sales Analysis
13.6. Audentes Therapeutics
13.6.1. Company Overview
13.6.2. Product Portfolio
13.6.3. Sales Analysis
13.7. EpiVax
13.7.1. Company Overview
13.7.2. Product Portfolio
13.7.3. Sales Analysis
13.8. Oxyrane
13.8.1. Company Overview
13.8.2. Product Portfolio
13.8.3. Sales Analysis
13.9. Sangamo BioSciences
13.9.1. Company Overview
13.9.2. Product Portfolio
13.9.3. Sales Analysis
13.10. Valerion Therapeutics
13.10.1. Company Overview
13.10.2. Product Portfolio
13.10.3. Sales Analysis
14. Conclusion & Recommendations
15. Glossary
15.1. Associated Visiongain Reports
15.2. Visiongain Report Sales Order Form
15.3. About Visiongain
15.4. Visiongain report evaluation form
List of Tables
Table 4.1. Global Pompe Disease Market, by Therapy Type, Forecast ($Mn, AGR%), 2020-2030
Table 4.2. Global Pompe Disease Market for Enzyme Replacement Therapy, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 4.3. Global Pompe Disease Market for Substrate Reduction Therapy, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.1. Global Pompe Disease Market, by Dosage Forms, Forecast ($Mn, AGR%), 2020-2030
Table 5.2. Global Pompe Disease Market for Solid, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 5.3. Global Pompe Disease Market for Liquid, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 6.1. Global Pompe Disease Market, by End User, Forecast ($Mn, AGR%), 2020-2030
Table 6.2. Global Pompe Disease Market for Hospitals & Clinics, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 6.3. Global Pompe Disease Market for Research and Academic Institutes, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 8.1 North American Pompe Disease Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 8.2 North American Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 8.3 North American Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 8.3 North American Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 8.4 US Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 8.5 US Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 8.6 US Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 8.7 Canada Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 8.7 Canada Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 8.8 Canada Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.1 Europe Pompe Disease Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 9.2 Europe Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.3 Europe Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.4 Europe Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.5 Germany Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.6 Germany Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.7 Germany Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.8 France Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.9 France Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.10 France Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.11 UK Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.12 UK Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.13 UK Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.14 Spain Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.15 Spain Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.16 Spain Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.17 Italy Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.18 Italy Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.19 Italy Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 9.20 Rest of Europe Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 9.21 Rest of Europe Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 9.22 Rest of Europe Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.1 Asia-Pacific Pompe Disease Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 10.2 Asia-Pacific Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.3 Asia-Pacific Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.4 Asia-Pacific Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.5 China Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.6 China Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.7 China Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.8 Japan Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.9 Japan Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.10 Japan Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.11 India Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.12 India Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.13 India Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.14 Australia Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.15 Australia Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.16 Australia Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 10.17 Rest of Asia-Pacific Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 10.18 Rest of Asia-Pacific Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 10.19 Rest of Asia-Pacific Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 11.1 Latin America Pompe Disease Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 11.2 Latin America Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 11.3 Latin America Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 11.4 Latin America Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 11.5 Brazil Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 11.6 Brazil Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 11.7 Brazil Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 11.8 Mexico Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 11.9 Mexico Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 11.10 Mexico Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 11.12 Rest of Latin America Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 11.13 Rest of Latin America Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 11.14 Rest of Latin America Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.1 Middle East & Africa Pompe Disease Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 12.2 Middle East & Africa Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 12.3 Middle East & Africa Pompe Disease Market Forecast, by Dosage Form, ($Mn, AGR%), 2020-2030
Table 12.4 Middle East & Africa Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.5 GCC Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 12.6 GCC Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.7 GCC Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.8 South Africa Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 12.9 South Africa Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.10 South Africa Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.11 Rest of Middle East & Africa Pompe Disease Market Forecast, by Therapy Type, 2020-2030 ($Mn, AGR%)
Table 12.12 Rest of Middle East & Africa Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 12.13 Rest of Middle East & Africa Pompe Disease Market Forecast, by End User, ($Mn, AGR%), 2020-2030
Table 13.1 Genzyme Product Portfolio
Table 13.2 BioMarin Pharmaceutical Product Portfolio
Table 13.3 Amicus Therapeutics Product Portfolio
Table 13.4 Avrobio, Inc. Product Portfolio
Table 13.5 Centogene AG Product Portfolio
Table 13.6 Audentes Therapeutics Product Portfolio
Table 13.7 EpiVax Product Portfolio
Table 13.8 Oxyrane Product Portfolio
Table 13.9 Sangamo BioSciences Product Portfolio
Table 13.10 Valerion Therapeutics Product Portfolio
List of Figures
Figure 4.1. Global Pompe Disease Market, by Therapy Type, Forecast ($Mn) 2020-2030
Figure 5.1. Global Pompe Disease Market, by Dosage Form, Forecast ($Mn) 2020-2030
Figure 6.1. Global Pompe Disease Market, by End User, Forecast ($Mn) 2020-2030
Figure 7.1. Global Pompe Disease Market, by Region, Forecast ($Mn), 2020-2030
Figure 8.1 North American Pompe Disease Market Forecast, ($Mn), 2020-2030
Figure 9.1 Europe Pompe Disease Market Forecast, ($Mn), 2020-2030
Figure 10.1 Asia-Pacific Pompe Disease Market Forecast, ($Mn), 2020-2030
Figure 11.1 Latin America Pompe Disease Market Forecast, ($Mn), 2020-2030
Figure 12.1 Middle East & Africa Pompe Disease Market Forecast, ($Mn), 2020-2030
Figure 13.1 Genzyme Sales Analysis ($Mn)
Figure 13.2 BioMarin Pharmaceutical Sales Analysis ($Mn)
Figure 13.3 Amicus Therapeutics Sales Analysis ($Mn)
Figure 13.4 Avrobio, Inc. Sales Analysis ($Mn)
Figure 13.5 Centogene AG Sales Analysis ($Mn)
Figure 13.6 Audentes Therapeutics Sales Analysis ($Mn)
Figure 13.7 EpiVax Sales Analysis ($Mn)
Figure 13.8 Oxyrane Sales Analysis ($Mn)
Figure 13.9 Sangamo BioSciences Sales Analysis ($Mn)
Figure 13.10 Valerion Therapeutics Sales Analysis ($Mn)